Glaukos
Glaukos, founded in 1998 and headquartered in Aliso Viejo, California, has offered corneal cross-linking for keratoconus since acquiring Avedro in 2019: the KXL system and riboflavin solutions.
Glaukos products
Glaukos, founded in 1998 and headquartered in Aliso Viejo, California, has offered corneal cross-linking for keratoconus since acquiring Avedro in 2019: the KXL system and riboflavin solutions.
This website contains information on medical devices intended for healthcare professionals (Czech Act No. 40/1995 Coll., on the Regulation of Advertising). Please confirm that you are a healthcare professional.